	US 12,460,254 B2
	Compositions, methods and kits for detecting Mycoplasma genitalium
Brett W. Kirkconnell, San Diego, CA (US); Barbara S. Weinbaum, La Jolla, CA (US); Damon K. Getman, Poway, CA (US); and Alice Jiang, San Diego, CA (US)
Assigned to Gen-Probe Incorporated, San Diego, CA (US)
Appl. No. 17/266,060
Filed by GEN-PROBE INCORPORATED, San Diego, CA (US)
PCT Filed Aug. 7, 2019, PCT No. PCT/US2019/045520 § 371(c)(1), (2) Date Feb. 4, 2021, PCT Pub. No. WO2020/033557, PCT Pub. Date Feb. 13, 2020.
Claims priority of provisional application 62/716,241, filed on Aug. 8, 2018.
Prior Publication US 2021/0310059 A1, Oct. 7, 2021
Int. Cl. C12Q 1/689 (2018.01); C12Q 1/6844 (2018.01)

CPC C12Q 1/6844 (2013.01) [C12Q 1/689 (2013.01)]

7 Claims

1. An oligonucleotide probe for detecting nucleic acids of Mycoplasma genitalium, consisting of:

a target-hybridizing sequence of bases consisting of SEQ ID NO:2 in which thymines may optionally be substituted with uracils, with a non-nucleotide linker positioned between bases 6 and 7 of SEQ ID NO:2; and

a detectable label attached to the non-nucleotide linker.